Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $3.67 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 5.73/1.58

View modes: 
3 stars

RE:Novo ranked in top 10 performers in 2014

rock07, As a Pirate friend/family member, you have NO right to post here.  Top performer???  Your papa almost bankrupted the company last year, thank you very much.  $2.15 is ONLY  3.3 CENTS pre...read more
4.5 stars

RE:RE:Take-over of NRI is imminent in my opinion...

Ronz, you brought up some very interesting points about who Goodman and Co.  In my opinion, Goodman (through Palladin and Knight) seem to be far too close (with possible side deals, or wink winks...read more
4.5 stars

RE:Take-over of NRI is imminent in my opinion...

Looking objectively at Nuvo's assets the biggest upside left is WF10 and a possible settlement of the lawsuit. I realize Nuvo has four FDA approved drugs BUT these are already under marketing...read more
3.5 stars

Take-over of NRI is imminent in my opinion...

Call it just a hunch, but with the consolidation going on in the sector, and certain companies with cash in hand looking to grab FDA approved drugs or late stage product potential that have marketing...read more
2.5 stars

Novo ranked in top 10 performers in 2014

10. Nuvo Research (TSX:NRI) +41.8% Closing Price December 31st, 2013: $2.15 Closing Price February 18th, 2014: $3.05 Shares of Nuvo Research caught fire early in January and haven’t looked back....read more
5 stars

I wonder why....

I wonder why there's no announcement about 2M Nuvo is entitle to receive following the approval of Pliaglis in Brazil....... probably Galderma delay the laungh of Pliaglis ...... and than no money for...read more
3 stars

there are games being played with the trading

watching this for the past couple weeks, the bids and asks are being shifted around constantly with clearly no intent to actually transact.  It's being boxed to ensure it stays  around the $3.00 level...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:Investor Presentation

Positive "sounding" news is used to bouy the stock if possible and then it's dilution time baby. Of course, management finds ways to "earn" the rewards needed to stay afloat and probably even boost...read more
1 star

RE:RE:RE:RE:RE:RE:Investor Presentation

The AGM is is also a special AGM. Knights takeout offer will be the first agenda item. Be aboard. Ignore the little folk.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:Investor Presentation

error corrected - paddypower wrote: July 2013, News Release on drawing down $4million more from Paladin's (15% eh?) loan: Nuvos Vice Presiden/Chief financial officer said:                            ...read more
5 stars

RE:RE:RE:RE:RE:Investor Presentation

Thanks for volunteering to represent thoe of us outsode of Canada, I dont' get my proxy codes in the mail prior to the voting deadloine), July 2013, New Release on drawing down $4million more from...read more
5 stars

RE:RE:RE:RE:Investor Presentation

absolutely disgusting. i can't believe what i'm seeing.  i am ashamed  i used to support these imbiciles.  this is robbery and they need to be stopped.  this agm will be unreal and i for one will be...read more
5 stars

RE:RE:RE:Investor Presentation

Before anticipating a buyout at $5.50/share, consider that the following dilution occurred during the past 9 months: This excludes shares/warrants issued under the Company's Benefits Plans. 1,390,000...read more
5 stars

RE:RE:Investor Presentation

Thanks also for the heads up, Rocky, you post without disclosing where and what you base your opinion on. You are forecasting a takeover with out any credibility. With all due respectm, you must be a...read more
2 stars

RE:Investor Presentation

Thanks for posting the link. Very good summary asset base and future potential. WF10 has all the makings of a home run. Knight will take this one out , not only for its obvious assets but also for...read more
5 stars

Investor Presentation

April 2014 Investor Presentation now on the Nuvo website.  rate and reply
1 star

RE:RE:RE:consider This...

Well shoot, quit your yammering and sink in your life savings numchuk... the opportunity is passing you by!  rate and reply
3 stars

RE:RE:RE:Share Appreciation Rights Plan...

How could I be missing the bigget picture... they are just finding more ways to stuff investor money into their pockets.  rate and reply
4 stars

RE:RE:Share Appreciation Rights Plan...

I think you are missing the big picture gofx... First of all why is the Board continuing to pay out bonuses when it is clear the strategies have failed and the company has lost a lot of money while...read more
3 stars

RE:Share Appreciation Rights Plan...

Let me take a stab at this... what happens if the stock price experiences volatility?  If this falls back down do they get paid twice if the price magically rises again? Sounds like a fantastic...read more